Investors / United States / Global BioAccess Fund
Global BioAccess Fund
Venture capital · New York, NY, United States · North America
Global BioAccess Fund is a fund manager that invests in companies developing novel therapeutics and devices for serious unmet medical needs. It funds companies that need capital to support IND submission and clinical trials.
Invests inHealthcare & Biotech
In its own wordstherapeuticsmedical devicesoncologyimmunologycnsrare disease
Your fit with Global BioAccess Fund
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsGlobal BioAccess Fund lists 10 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Series A, 50% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 80% of its companies are based in United States. It invests most often alongside Sanofi Ventures, Agent Capital and Avego.
Counts come from funding rounds that name Global BioAccess Fund, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Global BioAccess Fund's whole history. Rounds on record name 2 companies; its own site lists 10. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 50% |
| Series B | 50% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 92th | 20% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 59th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Sanofi Ventures | 3 |
| Agent Capital | 2 |
| Avego | 2 |
| Catalio Capital Management | 2 |
| Jeito Capital | 2 |
| Seroba Life Sciences | 2 |
| 3B Future Health Fund | 1 |
| 8VC | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers10100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Global BioAccess Fund head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Global BioAccess Fund| Date | Company | Stage |
|---|---|---|
| 14 Oct 2026 | Series A | |
| 2 Oct 2025 | Series B |
Round details for Global BioAccess Fund
Amounts, full round histories and every co-investor in Global BioAccess Fund's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Acesion Pharma aims to develop more efficacious and safe drugs for the treatment of atrial fibrillation, the most common type of cardiac arrhythmia. | Healthcare & Biotech | Portfolio page | ||
| Altay Therapeutics develops small molecules to address serious diseases by inhibiting transcription factors | Healthcare & Biotech | Oct 2026Series A | Page + round | |
| Alveus Therapeutics develops treatments for obesity and weight loss maintenance | Healthcare & Biotech | Portfolio page | ||
| Cartography Biosciences is developing molecules that are lethal to cancer and safe for patients by analyzing massive datasets from individual human cells. | Healthcare & Biotech | Oct 2025Series B | Page + round | |
| Ensho Therapeutics is advancing a potential oral therapy to treat patients with inflammatory bowel disease (IBD). | Healthcare & Biotech | Portfolio page | ||
| Epsilogen is a company that discovers and develops immunoglobulin IgE, IgA and IgG-based therapeutics for the treatment of cancer | Healthcare & Biotech | Portfolio page | ||
| Nuvig Therapeutics develops innovative medicine for autoimmune diseases | Healthcare & Biotech | Portfolio page | ||
| Odyssey Therapeutics develops therapeutic candidates for autoimmune and inflammatory diseases | Healthcare & Biotech | Portfolio page | ||
| ShiraTronics develops a neuromodulation device to treat chronic migraine | Healthcare & Biotech | Portfolio page | ||
| Vittoria Biotherapeutics is a clinical-stage company that develops immunotherapies to address unmet clinical needs in oncology and immunology | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- globalbioaccess.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 2 Oct 2025
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Global BioAccess Fund's profile as data
Pull Global BioAccess Fund's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/globalbioaccess.com
# also
GET /v1/firms/globalbioaccess.com/portfolio
GET /v1/firms/globalbioaccess.com/coinvestors
GET /v1/firms/globalbioaccess.com/news